The global neurological biomarkers market is anticipated to grow at a CAGR of 12.4% during the forecast period (2023-2030). Neurological biomarkers assist in monitoring the progress of neurological disease and studying biological responses toward a treatment. Neurological biomarkers capture different characteristics of a disease such as pathogenicity and heterogeneity, which helps in the development of personalized treatment therapy. Rapid research, technological advances, and funding in the field of neurology have led to the introduction of novel biomarkers that are accurate, reliable, and sensitive. For instance, in 2022, Johns Hopkins University (Baltimore, Maryland), Howard Lederman, granted funding of $1.6 million over four years. Moreover, in 2022, Virginia Commonwealth University provided funding of $1.6 million for type-1 to establish biomarkers and clinical endpoints.
In addition, key players such as C?N’s Diagnostics, Neurosteer Ltd., Proteome Sciences PLC, and others are adopting numerous strategies such as collaboration, and new product launches in the field of the neurological biomarker to remain competitive in the marketplace. For instance, in September 2022, Metabolomics firm Metabolon partnered with the Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore (NTU Singapore) on the identification of biomarkers for a range of health conditions. Metabolon accesses data from an NTU Singapore-led population cohort study to identify biomarkers related to the prevention, diagnosis, and treatment of a range of conditions. Furthermore, in February 2023, C2N Diagnostics, LLC, announced it has received a $15 million program-related investment from GHR Foundation. This financing signifies the foundation’s deep commitment to the company and to reducing the global burden of Alzheimer’s disease through early detection and prevention. Through this funding, the company conducted additional clinical studies to continue building real-world evidence around the use of PrecivityAD and PrecivityAD2, blood tests in clinical care. The investment enables broader market access, expanded medical education, biomarker pipeline development, and infrastructure growth to facilitate global expansion.
To Request a Sample of our Report on Neurological Biomarkers Market: https://www.omrglobal.com/request-sample/neurological-biomarkers-market
Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Neurological Biomarkers Market Report Segment
By Biomarker Type
- Imaging Biomarkers
- Metabolomics Biomarkers
- Proteomic Biomarkers
- Genomics Biomarkers
By Application
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Autism Spectrum Disorders
- Others (stroke, or epilepsy)
By End User
- Hospital
- Clinical Diagnostic Centers
- Research Organizations
A full report of Neurological Biomarkers Market available @ https://www.omrglobal.com/press-release/global-neurological-biomarkers-market
Neurological Biomarkers Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/neurological-biomarkers-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
